Quoin pharmaceuticals provides corporate update and announces third quarter 2023 financial results

Company reported positive clinical data for qrx003 from first six evaluable subjects in ongoing open-label netherton syndrome study
QNRX Ratings Summary
QNRX Quant Ranking